Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy

Bozcuk, HAKAN; Uslu, Gülcan; Samur, Mustafa; Yıldız, MUSTAFA; Ozben, TOMRİS; Özdoğan, Mustafa; Artaç, Mehmet; Altunbas, HASAN; Akan, Ilhan; Savaş, Burhan

doi:10.1016/j.cyto.2004.04.002

Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy

Atıf İçin Kopyala

Bozcuk H. Ş., Uslu G., Samur M., Yıldız M., Ozben T., Özdoğan M., ...Daha Fazla

CYTOKINE, cilt.27, sa.2-3, ss.58-65, 2004 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 27 Sayı: 2-3
Basım Tarihi: 2004
Doi Numarası: 10.1016/j.cyto.2004.04.002
Dergi Adı: CYTOKINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.58-65
Anahtar Kelimeler: breast cancer, chemotherapy, IL-6, insulin, TNF-alpha, GROWTH-FACTOR RECEPTOR, PROGNOSTIC FACTORS, FACTOR-I, CELLS, C-ERBB-2, IL-6, OVEREXPRESSION, AMPLIFICATION, EXPRESSION, RESISTANCE
Akdeniz Üniversitesi Adresli: Evet

Özet

Introduction: To assess the relationship of various growth factors and cytokines with the clinical outcome in metastatic breast cancer patients receiving chemotherapy.